This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Yoo Joong Kim: Innovator in TLR Modulation
Introduction
Yoo Joong Kim is a renowned inventor based in Saratoga, California, known for his significant contributions in the field of pharmaceutical innovation. With a focus on toll-like receptor modulators, his work plays a crucial role in advancing therapeutic options.
Latest Patents
Yoo Joong Kim holds a patent for solid forms of a toll-like receptor modulator. This invention provides crystalline forms, solvates, and hydrates of 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one, along with methods for their preparation. Such innovations are vital for enhancing drug efficacy and delivery.
Career Highlights
Kim is associated with Gilead Sciences, Inc., a leading biopharmaceutical company. His expertise in receptor modulation positions him as a valuable asset within the organization, where he continues to explore new avenues of research and development.
Collaborations
Throughout his career, Yoo Joong Kim has collaborated with talented colleagues, including Brandon Heath Brown and Fang Wang, who contribute to a dynamic work environment. Collaborations such as these foster innovation and lead to groundbreaking discoveries in the field.
Conclusion
Yoo Joong Kim's contributions to the realm of pharmaceutical innovation exemplify the impact of dedicated research and development. His patent on toll-like receptor modulators represents a significant step forward in therapeutic advancements, underscoring his role as an influential inventor in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile